nicardipine has been researched along with Cystic Fibrosis in 2 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nicardipine was administered intravenously or topically using iontophoresis or occlusive dressing." | 6.66 | The effect of nicardipine, a calcium channel blocker, on the sweat test in adult patients with cystic fibrosis. ( Butland, RJ; Greenland, JH; Hodson, ME; Roberts, CM; Saunders, C, 1989) |
| "Nicardipine was administered intravenously or topically using iontophoresis or occlusive dressing." | 2.66 | The effect of nicardipine, a calcium channel blocker, on the sweat test in adult patients with cystic fibrosis. ( Butland, RJ; Greenland, JH; Hodson, ME; Roberts, CM; Saunders, C, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roberts, CM | 2 |
| Butland, RJ | 2 |
| Saunders, C | 2 |
| Greenland, JH | 2 |
| Hodson, ME | 2 |
1 trial available for nicardipine and Cystic Fibrosis
| Article | Year |
|---|---|
The effect of nicardipine, a calcium channel blocker, on the sweat test in adult patients with cystic fibrosis.
Topics: Administration, Topical; Adolescent; Adult; Cystic Fibrosis; Female; Humans; Injections, Intradermal | 1989 |
1 other study available for nicardipine and Cystic Fibrosis
| Article | Year |
|---|---|
The effect of nicardipine, a calcium channel blocker, on the sweat test in adult patients with cystic fibrosis.
Topics: Adult; Cystic Fibrosis; Humans; Nicardipine; Sodium; Sweat | 1990 |